The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Low platelet mitochondrial complex I and complex II/III activity in early untreated parkinson's disease
Abstract
Following the discovery of inhibition of electron transport complex I by the neurotoxin 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP), which produces a parkinsonian syndrome in humans, monkeys, and mice, several laboratories have reported abnormalities of complex I and other electron transport complexes (ETCs) in various tissues from patients with Parkinson's disease (PD). Criticism of the significance of these findings in the etiology of PD has centered on whether drug treatments or the debilitation of the disease process itself produced the low ETC activities. We present results from a blinded study of platelet mitochondrial ETC activities in 18 early untreated PD patients and 18 age‐ and sex‐matched controls and in 13 spousal controls. Lower complex I activity in platelet mitochondria of PD patients was seen in early untreated disease and thus cannot be due to debilitation or drug therapy. Home environmental factors seem an unlikely explanation for the reduced complex I activity in PD patients but have not been excluded. Complex II/III activity was also reduced by 20% in PD compared with age‐/sex‐matched controls. The low complex I and II/III activities in platelet mitochondria appear to be related to the etiology of PD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An impairment of mitochondrial complex-I activity has been observed in the substantia nigra (SN), platelets, and skeletal muscle of PD patients 1, 9-13, in some but not in all studies14, 15.”
From Mitochondrial Approaches for Neuroprotection (2008) · cites this paper as [9]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. A. D., Dexter, D. T., Jenner, P. G., Clark, J. B., & MARSDEN, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,757
Abnormalities of the electron transport chain in idiopathic parkinson's disease
Parker, W. D., Boyson, S. J., & Parks, J. K. (1989) · Annals of Neurology · doi:10.1002/ana.410260606 · Cited by 1,061
Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain
Mecocci, P., MacGarvey, U., Kaufman, A. E., Koontz, D., Shoffner, J. M., Wallace, D. C., & Beal, M. F. (1993) · Annals of Neurology · doi:10.1002/ana.410340416 · Cited by 757
CENTRAL CERVICAL CORD SYNDROME AFTER HEADING A FOOTBALL
Scoppetta, C., & Vaccario, M. L. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92517-5 · Cited by 755
Deficiencies in Complex I subunits of the respiratory chain in Parkinson's disease
Mizuno, Y., Ohta, S., Tanaka, M., Takamiya, S., Suzuki, K., SATO, T. A., Oya, H., Ozawa, T., & Kagawa, Y. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91141-8 · Cited by 735
Spectrophotometric Assay of Cytochrome c Oxidase
Smith, L. (1955) · Methods of biochemical analysis · doi:10.1002/9780470110188.ch13 · Cited by 506
Mitochondrial DNA Variants Observed in Alzheimer Disease and Parkinson Disease Patients
Shoffner, J. M., Brown, M. D., Torroni, A., Lott, M. T., Cabell, M. F., Mirra, S. S., Beal, M. F., Yang, C.-C., Gearing, M., Salvo, R., et al. (1993) · Genomics · doi:10.1006/geno.1993.1299 · Cited by 450
[2] Citrate synthase from rat liver
Shepherd, D., & Garland, P. B. (1969) · Methods in Enzymology · doi:10.1016/0076-6879(69)13006-2 · Cited by 434
Platelet mitochondria function in Parkinson's disease
Krige, D., Carroll, M. T., Cooper, J. A. D., MARSDEN, C. D., & Schapira, A. H. V. (1992) · Annals of Neurology · doi:10.1002/ana.410320612 · Cited by 358
Parkinson's disease in 65 pairs of twins and in a set of quadruplets
Ward, C. D., Duvoisin, R. C., Ince, S. E., Nutt, J., Eldridge, R., & Calne, D. B. (1983) · Neurology · doi:10.1212/wnl.33.7.815 · Cited by 347
BRAIN, SKELETAL MUSCLE AND PLATELET HOMOGENATE MITOCHONDRIAL FUNCTION IN PARKINSON'S DISEASE
MANN, V. M., COOPER, J. M., KRIGE, D., DANIEL, S. E., SCHAPIRA, A. H. V., & MARSDEN, C. D. (1992) · Brain · doi:10.1093/brain/115.2.333 · Cited by 346
Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence
Ikebe, S.-I., Tanaka, M., Ohno, K., Sato, W., Hattori, K., Kondo, T., Mizuno, Y., & Ozawa, T. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)90497-b · Cited by 341
Mitochondrial oxidative phosphorylation defects in parkinson's disease
Shoffner, J. M., Watts, R. L., Juncos, J. L., Torroni, A., & Wallace, D. C. (1991) · Annals of Neurology · doi:10.1002/ana.410300304 · Cited by 333
Risk factors for Parkinson's disease
Hubble, J. P., Cao, T., Hassanein, R. E. S., Neuberger, J. S., & Roller, W. C. (1993) · Neurology · doi:10.1212/wnl.43.9.1693 · Cited by 279
Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in parkinson's disease
Hattori, N., Tanaka, M., Ozawa, T., & Mizuno, Y. (1991) · Annals of Neurology · doi:10.1002/ana.410300409 · Cited by 275
MITOCHONDRIAL FUNCTION IN PARKINSON'S DISEASE
Bindoff, L. A., Birch‐Machin, M. A., Cartlidge, N. E. F., Parker, W. D., & Turnbull, D. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90291-2 · Cited by 245
Singer, T. P., Castagnoli, N., Ramsay, R. R., & Trevor, A. J. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb03384.x · Cited by 244
Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease
Bindoff, L. A., Birch‐Machin, M. A., Cartlidge, N. E. F., Parker, W. D., & Turnbull, D. M. (1991) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(91)90311-t · Cited by 229
Neuroleptic medications inhibit complex I of the electron transport chain
Burkhardt, C., Kelly, J. P., Lim, Y., Filley, C. M., & Parker, W. D. (1993) · Annals of Neurology · doi:10.1002/ana.410330516 · Cited by 223
Benecke, R., Strumper, P., & Weiss, H. (1993) · Brain · doi:10.1093/brain/116.6.1451 · Cited by 220
Evidence for mitochondrial dysfunction in Parkinson's disease—a critical appraisal
Schapira, A. H. V. (1994) · Movement Disorders · doi:10.1002/mds.870090202 · Cited by 218
Janetzky, B., Hauck, S., Youdim, M. B. H., Riederer, P. F., Jellinger, K. A., Pantucek, F., ̈chling, R. Z., Boissl, K. W., & Reichmann, H. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90372-7 · Cited by 206
Nagatsu, T., & Yoshida, M. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90166-8 · Cited by 196
Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease
Yoshino, H., Nakagawa-Hattori, Y., Kondo, T., & Mizuno, Y. (1992) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02257619 · Cited by 195
[3] Preparation and properties of NADH: Ubiquinone oxidoreductase (complex I), EC 1.6.5.3
Hatefi, Y. (1978) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(78)53006-1 · Cited by 194
Ozawa, T., Tanaka, M., Ikebe, S.-I., Ohno, K., Kondo, T., & Mizuno, Y. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)90698-m · Cited by 187
Ecogenetics of Parkinson's Disease: Prevalence and Environmental Aspects in Rural Areas
Barbeau, A., Roy, M., Bernier, G. P., Campanella, G., & Paris, S. (1987) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100026147 · Cited by 174
Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity
Przedborski, S., Jackson-Lewis, V. R., Muthane, U. B., Jiang, H., Ferreira, M., Naini, A., & Fahn, S. (1993) · Annals of Neurology · doi:10.1002/ana.410340515 · Cited by 149
A clinical genetic study of Parkinson's disease
Lazzarini, A. M., Myers, R. H., Zimmerman, T. R., Mark, M. H., Golbe, L. I., Sage, J. I., Johnson, W. G., & Duvoisin, R. C. (1994) · Neurology · doi:10.1212/wnl.44.3_part_1.499 · Cited by 137
Normal Mitochondrial Genome in Brain from Patients with Parkinson's Disease and Complex I Defect
Lestienne, P. P., Nelson, J., Riederer, P. F., Jellinger, K. A., & Reichmann, H. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04973.x · Cited by 129
Mizuno, Y., Suzuki, K., & Ohta, S. (1990) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(90)90056-s · Cited by 129
Sayre, L. M. (1989) · Toxicology Letters · doi:10.1016/0378-4274(89)90168-9 · Cited by 115
Fatal Lactic Acidosis in Infancy with a Defect of Complex III of the Respiratory Chain
Birch‐Machin, M. A., Shepherd, I. M., Watmough, N. J., Sherratt, H. S. A., Bartlett, K., Darley-Usmar, V. M., Milligan, D. W. A., Welch, R. J., Aynsley-Green, A., & Turnbull, D. M. (1989) · Pediatric Research · doi:10.1203/00006450-198905000-00025 · Cited by 106
Methods for Study of Normal and Abnormal Skeletal Muscle Mitochondria
Sherratt, H. S. A., Watmough, N. J., Johnson, M. A., & Turnbull, D. M. (1988) · Methods of biochemical analysis · doi:10.1002/9780470110546.ch6 · Cited by 93
Energy metabolism of blood platelets
Salganicoff, L., & Fukami, M. H. (1972) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(72)90391-8 · Cited by 49
The biochemical basis of neuropharmacology
Bruyn, G. W. (1987) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(87)90245-0 · Cited by 47
Bravi, D., Anderson, J. J., Dagani, F., Davis, T. L., Ferrari, R., Gillespie, M., & Chase, T. N. (1992) · Movement Disorders · doi:10.1002/mds.870070307 · Cited by 43
No evidence for altered muscle mitochondrial function in Parkinson's disease.
Anderson, J. J., Bravi, D., Ferrari, R., Davis, T. L., Baronti, F., Chase, T. N., & Dagani, F. (1993) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.56.5.477 · Cited by 39
Suzuki, K., Mizuno, Y., & Yoshida, M. (1990) · PubMed · Cited by 37
Subcellular fractionation of pig platelets
Salganicoff, L., Hebda, P. A., Yandrasitz, J. R., & Fukami, M. H. (1975) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(75)90369-4 · Cited by 34
Stumpf, D. A., & Parks, J. K. (1981) · Biochemical Medicine · doi:10.1016/0006-2944(81)90080-6 · Cited by 33
PCR Analysis of platelet mtDNA: Lack of specific changes in Parkinson's disease
Sandy, M. S., Langston, J. W., Smith, M. T., & Monte, D. A. D. (1993) · Movement Disorders · doi:10.1002/mds.870080114 · Cited by 32
Selective inhibition of complex I of the brain electron transport system by tetrahydroisoquinoline
Suzuki, K., Mizuno, Y., & Yoshida, M. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)90850-4 · Cited by 28
Monozygotic twins with Parkinson's disease
Koller, W. C., O'Hara, R., Nutt, J., Young, J. D., & Rubino, F. A. (1986) · Annals of Neurology · doi:10.1002/ana.410190420 · Cited by 15
Flagged first, then by citations
Research works printed but not linked: 1
- Lang AET, 1989, Quantification of neurological deficit, 289
Cited by
Sorted by citations
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 2,072
Mechanism of Toxicity in Rotenone Models of Parkinson's Disease
Sherer, T., Betarbet, R. S., Testa, C. M., Seo, B. B., Richardson, J. R., Kim, J. H., Miller, G. W., Yagi, T., Matsuno‐Yagi, A., & Greenamyre, J. T. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-34-10756.2003 · Cited by 1,102
Effects of Coenzyme Q10 in Early Parkinson Disease: Evidence of Slowing of the Functional Decline
Shults, C. W. (2002) · Archives of Neurology · doi:10.1001/archneur.59.10.1541 · Cited by 984
Self-citationMitochondrial dysfunction and oxidative stress in Parkinson's disease
Subramaniam, S., & Chesselet, M. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.04.004 · Cited by 953
Mitochondria in the aetiology and pathogenesis of Parkinson's disease
Schapira, A. H. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70327-7 · Cited by 883
Metadata
- Authors
- Haas, R. H., Nasirian, F., Nakano, K., Ward, D., Pay, M., Hill, R., & Shults, C. W.
- Affiliations
- University of California San Diego (US)
- Veterans Health Administration (US)
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1995-06
- Volume
- 37
- Issue
- 6
- Pages
- 714-722
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2112777355
- Cited by
- 435
- References
- 47
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 6 · 2023: 9 · 2022: 14 · 2021: 14 · 2020: 19 · 2019: 23 · 2018: 13 · 2017: 18 · 2016: 8 · 2015: 22 · 2014: 9 · 2013: 15 · 2012: 11
- FWCI
- 7.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ns029504-03)
- National Institute of Neurological Disorders and Stroke (R01 NS29504)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Keywords
- Parkinson's disease, platelet mitochondria, mitochondrial electron transport chain, complex I, MPTP, etiology, mitochondrial dysfunction
- MeSH terms
- Adult, Aged, Blood Platelets, Citrate (si)-Synthase, Female, Humans, Male, Middle Aged, Mitochondria, Multienzyme Complexes, Oxidoreductases, Parkinson Disease, Smoking, Succinate Dehydrogenase, Electron Transport Complex III, NAD(P)H Dehydrogenase (Quinone), Electron Transport Complex II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review